Research Archive — Page 4 of 139
-
August 18, 2026
Could GLP-1s help treat opioid use disorder? Vanderbilt Health study now enrolling
The study, Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder (TAB), is a double-blind, randomized, placebo-controlled trial conducted through the National Institute on Drug Abuse’s Clinical Trials Network. -
August 18, 2026
Vanderbilt Health’s Annet Kirabo to receive major award for hypertension research
The award will be presented Oct. 10 during the American Heart Association’s Hypertension Scientific Session in Arlington, Virginia. -
August 14, 2026
EHR-embedded tool extracts liver stiffness values to prevent gaps in care
Vanderbilt Health researchers developed a natural language processing tool that can efficiently identify patients with liver disease and streamline assessment for treatments. -
August 12, 2026
Study points to new therapeutic target for chronic kidney disease
Researchers showed that blocking the protein cadherin-11 improved survival and kidney function in three kidney injury models. -
August 12, 2026
Alexander Bick to lead cutting-edge resource for genomic discovery at Vanderbilt Health
Vanderbilt Technologies for Advanced Genomics is a one-stop genomics research resource that offers sample biobanking, genome sequencing, single-cell and spatial multiomic profiling, and other specialized services. -
August 11, 2026
Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older
"C. diff is one of those infections that turns a routine hospital stay or a course of antibiotics into something far more serious, and older adults bear the brunt of it." -
August 10, 2026
Molecular mapping reveals hidden cellular programs in heart transplant rejection
Study provides a unique resource to guide future research on acute rejection diagnosis, therapeutic response prediction, and risk for chronic rejection.